U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07167160) titled 'Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial' on Sept. 01.
Brief Summary: Efficacy evaluation of camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Cervical Cancer
Immunochemotherapy
Intervention:
DRUG: Camrelizumab combined with chemotherapy
Camrelizumab combined with chemotherapy for adjuvant treatment of patients with pathologically confirmed lymph node-positive cervical cancer after staging surgery
Recruitment Status: NOT_YET_RECRUI...